Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential
dc.contributor.author | Burdon, Tom J. | |
dc.contributor.author | Paul, Arghya | |
dc.contributor.author | Noiseux, Nicolas | |
dc.contributor.author | Prakash, Satya | |
dc.contributor.author | Shum-Tim, Dominique | |
dc.date.accessioned | 2015-10-09T17:36:53Z | |
dc.date.available | 2015-10-09T17:36:53Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Burdon, Tom J., Arghya Paul, Nicolas Noiseux, Satya Prakash, and Dominique Shum-Tim. "Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential." Bone Marrow Research 2011 (2011): 1-14. http://dx.doi.org/10.1155/2011/207326. | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/18624 | |
dc.description.abstract | During the past several years, there has been intense research in the field of bone marrow-derived stem cell (BMSC) therapy to facilitate its translation into clinical setting. Although a lot has been accomplished, plenty of challenges lie ahead. Furthermore, there is a growing body of evidence showing that administration of BMSC-derived conditioned media (BMSC-CM) can recapitulate the beneficial effects observed after stem cell therapy. BMSCs produce a wide range of cytokines and chemokines that have, until now, shown extensive therapeutic potential. These paracrine mechanisms could be as diverse as stimulating receptor-mediated survival pathways, inducing stem cell homing and differentiation or regulating the anti-inflammatory effects in wounded areas. The current review reflects the rapid shift of interest from BMSC to BMSC-CM to alleviate many logistical and technical issues regarding cell therapy and evaluates its future potential as an effective regenerative therapy. | en_US |
dc.publisher | Hindawi Publishing Corporation | en_US |
dc.relation.isversionof | dx:10.1155/2011/207326 | en_US |
dc.rights | Copyright © 2011 Tom J. Burdon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential | en_US |
dc.type | Article | |
kusw.kuauthor | Paul, Arghya | |
kusw.kudepartment | Chemical & Petroleum Engr | en_US |
kusw.oaversion | Scholarly/refereed, publisher version | |
kusw.oapolicy | This item meets KU Open Access policy criteria. | |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as: Copyright © 2011 Tom J. Burdon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.